During a retroactive review of past complaints for potential adverse events, conducted as a capa in response to a recent fda inspection, a reportable adverse event was discovered.On (b)(6) 2014 a zoll territory mgr (tm) contacted zoll customer support to report that a (b)(6) female pt had a rash.During a follow up with the pt the pt reported having lesions, blood blisters and regular blisters.She stated that her whole upper body was covered in a rash and she had sores.The pt reported that she spoke to her cardiologist and he determined that she was allergic to the metals in the life vest.The pt ended use of the lifevest.It is unk whether the pt required med intervention.The clinical outcome of the skin irritation is unk.
|